Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15499
Abstract: Multiple myeloma accounts for over 10–15% of haematological malignancies. Continued molecular advances have resulted in the development of new drugs for treatment of multiple myeloma. Four drugs were approved by the Food and Drug Administration… read more here.
Keywords: complications modern; modern multiple; myeloma; cardiovascular complications ... See more keywords